Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,719
Closed -$594K 1022
2022
Q3
$594K Buy
+2,719
New +$619K 0.04% 588
2021
Q4
Sell
-3,336
Closed -$879K 1332
2021
Q3
$879K Buy
+3,336
New +$912K 0.05% 569
2020
Q2
Sell
-1,985
Closed -$292K 1568
2020
Q1
$292K Sell
1,985
-69,415
-97% -$11.1M 0.01% 1176
2019
Q4
$11.1M Sell
71,400
-8,256
-10% -$1.19M 0.16% 201
2019
Q3
$10.8M Buy
79,656
+63,070
+380% +$8.26M 0.13% 198
2019
Q2
$2.02M Buy
16,586
+13,184
+388% +$1.46M 0.04% 287
2019
Q1
$354K Sell
3,402
-117,352
-97% -$12.1M 0.01% 733
2018
Q4
$13.8M Buy
120,754
+106,967
+776% +$11.5M 0.3% 127
2018
Q3
$1.59M Buy
13,787
+7
+0.1% +$767 0.03% 328
2018
Q2
$1.43M Sell
13,780
-59,288
-81% -$6M 0.04% 366
2018
Q1
$7.2M Sell
73,068
-1,110
-1% -$105K 0.2% 125
2017
Q4
$6.28M Buy
74,178
+66,102
+818% +$5.46M 0.18% 160
2017
Q3
$622K Buy
8,076
+640
+9% +$49K 0.02% 502
2017
Q2
$579K Buy
+7,436
New +$532K 0.02% 479
2016
Q4
Sell
-197,404
Closed -$12.8M 484
2016
Q3
$12.8M Buy
197,404
+98,696
+100% +$6.57M 0.22% 162
2016
Q2
$6.24M Buy
98,708
+75,978
+334% +$4.48M 0.1% 225
2016
Q1
$1.31M Sell
22,730
-414,893
-95% -$23.5M 0.01% 281
2015
Q4
$23.5M Buy
437,623
+52,824
+14% +$2.98M 0.21% 183
2015
Q3
$19.6M Sell
384,799
-96,047
-20% -$5.17M 0.16% 233
2015
Q2
$27.1M Sell
480,846
-146,275
-23% -$9.23M 0.25% 156
2015
Q1
$45M Buy
627,121
+553,651
+754% +$36M 0.36% 97
2014
Q4
$4.12M Sell
73,470
-83,689
-53% -$4.37M 0.05% 339
2014
Q3
$7.74M Sell
157,159
-322,485
-67% -$16.4M 0.06% 344
2014
Q2
$24.3M Buy
+479,644
New +$23.8M 0.17% 244

Other funds holding RMD

Winton Group's RMD Position: Q4 2022 in Review

Winton Group sold out of ResMed (RMD) in Q4 2022, closing a stake of 2,719 shares — an estimated $594K sold.

Winton Group first reported a position in RMD in Q2 2014 and held it in 24 quarters. The position peaked at $45M in Q1 2015. 731 funds tracked by Wall St. Rank hold RMD as of Q4 2022.

  • Winton Group reported no remaining ResMed position as of Q4 2022 after selling out during the quarter.
  • Winton Group sold 2,719 ResMed shares in Q4 2022, an estimated $594K.
  • Winton Group first reported a position in ResMed in Q2 2014 and held it in 24 quarters.
  • Winton Group's ResMed position peaked at $45M in Q1 2015.
  • 731 funds tracked by Wall St. Rank held ResMed as of Q4 2022.

Based on Winton Group's 13F filing for Q4 2022, filed 14 Feb 2023.